Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

04:03 EST 19th November 2018 | BioPortfolio

Showing News Articles 1–25 of 430,000+

Monday 19th November 2018

Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye

Melbourne, Australia, November 19, 2018 / B3C newswire / -- Bionic Vision Technologies Pty Ltd (BVT) today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne. Researchers said they were “very pleased” with the progress of all four patients who have had a “sense of sight” restored. All ...

APEC's Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). Aims to define, diagnose and support rare disease patients through innovation, education, building capacity and aligning policies across the 21 APEC member...

National Institute on Aging Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryNational Institute on Aging NIA, a subsidiary of National Institutes of Health is a healthcare institute that offers health and aging care services. The institute conducts research on aging through researchers and the international community of scientists. Its services comprise research, extramural program, research funding, training, intramural program, basic, clinical research and health ...

Shanxi Zhendong Pharmaceutical Co Ltd 300158 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryShanxi Zhendong Pharmaceutical Co Ltd Zhendong Group is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, respiratory drugs; antibiotics, antitumor drugs, vitamins, Chinese medicines, calcium preparations, active ...

Active Biotech's election committee appointed

PRESS RELEASE In accordance with a decision made by the Annual General Meeting held on May 17, 2018, the Election Committee shall comprise the representatives for the three largest shareholders by votes, as per end of September 2018, and the Chairman of the Board. For the 2019 Annual General Meeting, the Election Committee shall propose Board members and a Chairman of the Boa...

PCI launches Pharmacist Registration and Tracking System to capture pharmacist data pan India

In a bid to streamline registered pharmacists' micro level data collection at pan─India level, the Pharmacy Council of India (PCI) has launched a national digital platform for registration and tracking of pharmacists titled Pharmacist Registration and Tracking System (PRTS).

Obalon Therapeutics Inc OBLN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryObalon Therapeutics Inc Obalon Therapeutics is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gastric balloon for weight loss therapy. Obalon Therapeutics' Obalon Balloon System is a swallowable intrag...

AstraZeneca’s Imfinzi fails to improve OS in Mystic lung cancer trial

The company has reported the final OS results for the phase III Mystic trial, which is a study of Imfinzi monotherapy and the combination of Imfinzi and anti-CTLA4 The post AstraZeneca’s Imfinzi fails to improve OS in Mystic lung cancer trial appeared first on Pharmaceutical Business review.

iMDsoft Inc Strategic SWOT Analysis Review [Report Updated: 18092018] Prices from USD $125

iMDsoft Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by enab...

Warm Temps at Winter’s Peak Only Part of Package for 2019 iaedp™ Symposium

The International Association of Eating Disorders Professionals (iaedp™) Foundation will hold its 33rd annual Symposium at the JW Marriott Desert Springs Resort during February 7 – 10, 2019. PEKIN, Ill. (PRWEB) November 19, 2018 The International Association of Eating Disorders Professionals (iaedp™) Foundation will hold its 33rd annual Symposium at the JW Marriott Desert Springs Resort dur...

Good Leads® Extends the "End of Year" Incentive Plan for Outsourced B2B Lead Generation Services

Good Leads® is extending the "EOY” incentive plan with a 2 month offering and financing for outsourced B2B Lead Generation services. Good Leads will rapidly deploy a Strategic Strike inside sales team under their Prospect Builder® Program and extend delayed payments till the end of the contract term in 2019. SALEM, N.H. (PRWEB) November 19, 2018 Good Leads® is extending the ...

Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several chronic inflammatory diseases NLRP3 is associated with harmful inflammation in a broad range of serious medical conditions including Alzheimer’s, Parkinson’s, inflammatory bowel disease, gout,...

GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES

FOR IMMEDIATE RELEASE GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), November 19, 2018 - GENFIT SA (Euronext: GNFT), a French biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those of metabo...

Biocept Inc BIOC Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryBiocept Inc Biocept is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell CTC and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, nonsmall cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreat...

iCAD Inc ICAD Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryiCAD Inc iCAD develops and markets computer aided detection CAD solutions and workflow solutions for mammography filmbased, digital radiography DR and computed radiography CR, Magnetic Resonance Imaging MRI, and Computed Tomography CT. iCAD products find application in detection and treatment of breast, prostate and colorectal cancers. The company markets products through direct sales organ...

Boehringer partners with Epizyme to develop new cancer therapies

Boehringer Ingelheim has formed a global alliance with US-based biopharmaceutical firm Epizyme for the research, development and commercialisation of new...Read More... The post Boehringer partners with Epizyme to develop new cancer therapies appeared first on Pharmaceutical Technology.

Zur Rose Group announces the terms of the planned capital increase by way of a rights offering

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 19.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegroup.com/websites/zurrosegroup/English/2015/acquisition-medpex.html     End of Corporate News ...

Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Financing led by Forbion, with Longitude Capital and founding investors, Novartis Venture Fund and Fountain Healthcare Partners, also participating Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several inflammatory diseases NLRP...

Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis

The first-in-human study will be initiated early next year Orphan Drug Designation application was filed for IPF SEONGNAM, South Korea, Nov. 18, 2018 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the company filed an Investigational New Drug (IND) appl...

As Brexit Looms, Biopharma Industry Prepares for the Worst http://dlvr.it/QrZ7l4 pic.twitter.com/GSyog36wdv

As Brexit Looms, Biopharma Industry Prepares for the Worst http://dlvr.it/QrZ7l4  pic.twitter.com/GSyog36wdv

The Downside of Offering to Help out at Work http://dlvr.it/QrZ7dz pic.twitter.com/EIz5gPYhl7

The Downside of Offering to Help out at Work http://dlvr.it/QrZ7dz  pic.twitter.com/EIz5gPYhl7

Novozymes AS NZYM B Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryNovozymes AS Novozymes is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment and bioinnovation solutions to minimize the CO2 emissions. Novozymes's produc...

BrainCool AB BRAIN Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryBrainCool AB BrainCool, a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company's products are based on the principle that applying therapeutic hypothermia contributes considerably to improved survival after an episode of cardiac arrest. The company's product portfoli...

How the gut ‘talks’ to brown fat

The long known gut hormone secretin has a newly discovered, additional function: It activates thermogenesis in brown fat, which triggers saturation. Scientists of the Technical University of Munich (TUM) in collaboration with an international team have succeeded in this important step. Only a few w...

Biosense Webster Launches Report - The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic Across Europe

New report released during AF Association Global AF Aware Week highlights AF as one of the world’s most significant health issues Shows need for greater awareness of AF and its impact on patients and on healthcare systems across Europe By 2030 the number of people with AF is projected to increase by up to 70%1...


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.